BlackRock, Inc. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 09:12 am Sale | 2025-03-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 3,525,532 6.400% | -1,934,409 (-35.43%) | Filing |
| 2024-08-07 4:10 pm Purchase | 2024-07-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 5,459,941 10.000% | 2,827,262 (+107.39%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 2,632,679 6.000% | 1,690,013 (+179.28%) | Filing |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 942,666 2.500% | -1,587,065 (-62.74%) | Filing |